Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bojar

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
European Urology|December 1, 1998
Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancerF Jankevicius, T Shibayama, K Decken, et al.
International Journal of Cancer|April 13, 2000
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study GroupC Schmoor, G Bastert, J Dunst, et al.
Cancer Research|August 1, 1986
Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter studyG Leclercq, H Bojar, J Goussard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Cancer Immunology, Immunotherapy : CII|November 5, 2020
Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institutionR Kleef, R Nagy, A Baierl, et al.
European Journal of Medical Research|August 11, 2010
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer diseaseC Matuschek, Edwin Bölke, G Lammering, et al.
Cancer Gene Therapy|January 5, 2002
Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant gliomaF W Floeth, N Shand, H Bojar, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 27, 2002
Gene expression profiles in the acutely dissected human aortaB T Müller, O Modlich, H B Prisack, et al.
European Journal of Medical Research|August 12, 2009
Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patientsE Bölke, K Orth, P A Gerber, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Urology|December 1, 1998
Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancerF Jankevicius, T Shibayama, K Decken, et al.
International Journal of Cancer|April 13, 2000
Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients. The German Breast-Cancer Study GroupC Schmoor, G Bastert, J Dunst, et al.
Cancer Research|August 1, 1986
Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter studyG Leclercq, H Bojar, J Goussard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Cancer Immunology, Immunotherapy : CII|November 5, 2020
Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institutionR Kleef, R Nagy, A Baierl, et al.
European Journal of Medical Research|August 11, 2010
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer diseaseC Matuschek, Edwin Bölke, G Lammering, et al.
Cancer Gene Therapy|January 5, 2002
Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant gliomaF W Floeth, N Shand, H Bojar, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 27, 2002
Gene expression profiles in the acutely dissected human aortaB T Müller, O Modlich, H B Prisack, et al.
European Journal of Medical Research|August 12, 2009
Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patientsE Bölke, K Orth, P A Gerber, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
Pageof 6